The Cannabidiol Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Source (Hemp, Marijuana), By B2B Sales (Pharmaceuticals, Wellness), By B2C Sales Channel (Hospital Pharmacies, Online, Retail Stores), By B2C End User (Medical, Personal Use), By End-User (Medical, Personal Use, Pharmaceuticals, Wellness).
The Cannabidiol market in 2024 reflects the growing popularity of cannabidiol (CBD) products derived from cannabis and hemp plants, offering potential health benefits without the psychoactive effects of tetrahydrocannabinol (THC). CBD products include oils, tinctures, capsules, and topicals, targeting various health conditions such as pain, anxiety, inflammation, and sleep disorders. Market dynamics are driven by factors such as increasing consumer interest in natural remedies, relaxation of regulatory restrictions on CBD products, and advancements in extraction and formulation technologies. Collaboration between researchers, manufacturers, retailers, and regulatory agencies drives innovation and market expansion in the CBD industry, offering diverse and accessible wellness solutions for consumers.
A prominent trend in the Cannabidiol market is the increasing acceptance and legalization of CBD products across various regions globally. As more countries legalize the use of cannabis-derived products for medical and recreational purposes, the market for CBD-based products, including oils, tinctures, capsules, and topical formulations, continues to expand. This trend is driven by growing consumer awareness of the potential health benefits of CBD, such as pain relief, anxiety reduction, and anti-inflammatory properties, leading to a surge in demand for CBD-infused products in wellness, beauty, and healthcare sectors.
The primary driver for the Cannabidiol market is the rising demand for natural and alternative therapies for various health conditions. Consumers are increasingly seeking natural remedies and supplements as alternatives to conventional pharmaceutical drugs, driven by concerns about side effects and dependency associated with traditional medications. CBD, derived from the cannabis plant, is perceived as a natural and holistic approach to wellness, attracting consumers looking for non-invasive solutions for managing ailments such as chronic pain, insomnia, epilepsy, and mood disorders. This growing consumer preference for natural remedies fuels the expansion of the Cannabidiol market.
An opportunity in the Cannabidiol market lies in the expansion of product offerings and formulations to cater to diverse consumer needs and preferences. Companies can capitalize on the versatility of CBD by developing a wide range of products tailored to specific demographic segments and health concerns. This includes developing innovative CBD-infused formulations such as beverages, edibles, skincare products, pet supplements, and pharmaceutical-grade medications. Additionally, investing in research and development to explore the therapeutic potential of CBD for emerging applications, such as neurodegenerative diseases, autoimmune disorders, and cancer therapy, can unlock new growth opportunities and differentiate brands in the Cannabidiol market landscape.
By Source
Hemp
Marijuana
By B2B Sales Type
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
By B2C Sales Channel
Hospital Pharmacies
Online
Retail Stores
By B2C End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
By End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
ENDOCA
Cannoid LLC
Canopy Growth Corp
Elixinol
Folium Europe B.V.
Isodiol International Inc
Medical Marijuana Inc
NuLeaf Naturals LLC
PharmaHemp
The Cronos Group
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Cannabidiol Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Cannabidiol Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Cannabidiol Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Cannabidiol Market Size Outlook, $ Million, 2021 to 2030
3.2 Cannabidiol Market Outlook by Type, $ Million, 2021 to 2030
3.3 Cannabidiol Market Outlook by Product, $ Million, 2021 to 2030
3.4 Cannabidiol Market Outlook by Application, $ Million, 2021 to 2030
3.5 Cannabidiol Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Cannabidiol Market Industry
4.2 Key Market Trends in Cannabidiol Market Industry
4.3 Potential Opportunities in Cannabidiol Market Industry
4.4 Key Challenges in Cannabidiol Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Cannabidiol Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Cannabidiol Market Outlook By Segments
7.1 Cannabidiol Market Outlook by Segments
By Source
Hemp
Marijuana
By B2B Sales Type
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
By B2C Sales Channel
Hospital Pharmacies
Online
Retail Stores
By B2C End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
By End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
8 North America Cannabidiol Market Analysis And Outlook To 2030
8.1 Introduction to North America Cannabidiol Markets in 2024
8.2 North America Cannabidiol Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Cannabidiol Market size Outlook by Segments, 2021-2030
By Source
Hemp
Marijuana
By B2B Sales Type
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
By B2C Sales Channel
Hospital Pharmacies
Online
Retail Stores
By B2C End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
By End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
9 Europe Cannabidiol Market Analysis And Outlook To 2030
9.1 Introduction to Europe Cannabidiol Markets in 2024
9.2 Europe Cannabidiol Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Cannabidiol Market Size Outlook By Segments, 2021-2030
By Source
Hemp
Marijuana
By B2B Sales Type
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
By B2C Sales Channel
Hospital Pharmacies
Online
Retail Stores
By B2C End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
By End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
10 Asia Pacific Cannabidiol Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Cannabidiol Markets in 2024
10.2 Asia Pacific Cannabidiol Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Cannabidiol Market size Outlook by Segments, 2021-2030
By Source
Hemp
Marijuana
By B2B Sales Type
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
By B2C Sales Channel
Hospital Pharmacies
Online
Retail Stores
By B2C End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
By End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
11 South America Cannabidiol Market Analysis And Outlook To 2030
11.1 Introduction to South America Cannabidiol Markets in 2024
11.2 South America Cannabidiol Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Cannabidiol Market size Outlook by Segments, 2021-2030
By Source
Hemp
Marijuana
By B2B Sales Type
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
By B2C Sales Channel
Hospital Pharmacies
Online
Retail Stores
By B2C End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
By End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
12 Middle East And Africa Cannabidiol Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Cannabidiol Markets in 2024
12.2 Middle East and Africa Cannabidiol Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Cannabidiol Market size Outlook by Segments, 2021-2030
By Source
Hemp
Marijuana
By B2B Sales Type
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
By B2C Sales Channel
Hospital Pharmacies
Online
Retail Stores
By B2C End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
By End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
ENDOCA
Cannoid LLC
Canopy Growth Corp
Elixinol
Folium Europe B.V.
Isodiol International Inc
Medical Marijuana Inc
NuLeaf Naturals LLC
PharmaHemp
The Cronos Group
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Source
Hemp
Marijuana
By B2B Sales Type
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
By B2C Sales Channel
Hospital Pharmacies
Online
Retail Stores
By B2C End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
By End-user
Medical
-Chronic Pain
-Mental Disorders
-Cancer
-Others
Personal Use
Pharmaceuticals
Wellness
-Food & Beverages
-Personal Care & Cosmetics
-Nutraceuticals
-Others
The global Cannabidiol Market is one of the lucrative growth markets, poised to register a 16.5% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
ENDOCA, Cannoid LLC, Canopy Growth Corp, Elixinol, Folium Europe B.V., Isodiol International Inc, Medical Marijuana Inc, NuLeaf Naturals LLC, PharmaHemp, The Cronos Group
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume